ClinVar

Description

p.Lys185GlufsTer55 (CTGAAG>CT{T}GAAG) : c.551dupT in exon 5 of the MYBPC3 gene (NM_000256.3). The variant Lys185GlufsTer55 (p.K185EfsX55) in the MYBPC3 gene has not been reported to our knowledge. However, it was observed in more than ten (10) unrelated families tested for HCM by the Molecular Diagnostics Laboratory of the Montreal Heart Institute. It meets the following criteria of pathogenicity of the ACMG : PVS1 : The duplication of a thymidine at position 551 causes a change in the reading frame for 55 amino acids and leads to a stop codon resulting in a shortened protein of 81%. This variant is expected to result in an abnormal product : a truncated protein or loss of protein production from this allele through nonsense-mediated accelerated decay of the mRNA. PM2 :Lys185GlufsTer55 was not reported in ExAC database (more than 120,000 alleles) and was not observed in the populations of the 1000 Genome Project (more than 5000 individuals) neither in the populations of European and African American ancestry in the NHLBI Exome Sequencing Project (more than 6500 individuals). This means it is not a common benign variant in these populations. PP5 :The variant was the subject of two submissions in ClinVar: both in pathogenic category. In summary, Lys185GlufsTer55 in the MYBPC3 gene combines a very strong criteria of pathogenicity, a moderate criteria and a supporting criteria. It is interpreted as pathogenic variant.